BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34426890)

  • 1. Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area.
    Kotani T; Nishimura M; Tamaki N; Matsushima S; Akiyama S; Kanayama T; Bamba C; Tanada Y; Nii T; Yamada K
    Ann Nucl Med; 2021 Dec; 35(12):1305-1311. PubMed ID: 34426890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic whole-body
    Nishimura M; Tamaki N; Matsushima S; Kiba M; Kotani T; Bamba C; Nakamura Y; Yamada K
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2293-2300. PubMed ID: 32189027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel objective method for discriminating pathological and physiological colorectal uptake in the lower abdominal region using whole-body dynamic
    Kato T; Ichikawa H; Shibutani T; Kita A; Watanabe M; Tada H; Sugiura A
    Ann Nucl Med; 2023 Oct; 37(10):561-571. PubMed ID: 37523072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of motion artifacts using dynamic whole-body
    Kaji T; Osanai K; Takahashi A; Kinoshita A; Satoh D; Nakata T; Tamaki N
    Jpn J Radiol; 2024 Apr; 42(4):374-381. PubMed ID: 38093138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A; Chaudhry M; Blakeley JO; Wahl R
    J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
    Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
    Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
    Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST
    World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
    J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanning.
    Miyake KK; Nakamoto Y; Togashi K
    Ann Nucl Med; 2012 Jul; 26(6):492-500. PubMed ID: 22492392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of water enema (18)F-fluorodexyglucose positron emission tomography and computed tomography in incidental finding of hypermetabolism focus in the colorectum].
    Zhang Z; Lyu Q; Chen F; Zhang J; Lu D; Hu P; Ma L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Mar; 17(3):239-44. PubMed ID: 24671811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging.
    Toriihara A; Yoshida K; Umehara I; Shibuya H
    Ann Nucl Med; 2011 Apr; 25(3):173-8. PubMed ID: 21088936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
    Peng J; He Y; Xu J; Sheng J; Cai S; Zhang Z
    Colorectal Dis; 2011 Nov; 13(11):e374-8. PubMed ID: 21831098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of laxative-augmented contrast medium in the evaluation of colorectal foci at FDG PET.
    Chen YK; Chen JH; Tsui CC; Chou HH; Cheng RH; Chiu JS
    Radiology; 2011 May; 259(2):525-33. PubMed ID: 21406631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.